News

Jan 14 2019

The Washington Post – A new study in Nature Genetics examined 56,000 pairs of twins from a database of 45 million people insured through Aetna to study how health and life span is affected by where people live, and found — as might be expected — a mixed picture of genetic and environmental factors on diseases and disor

Jan 13 2019

Vox – The Department of Justice, on behalf of the FDA, is suing two clinics for experimenting on patients with misleading products, including one in California that provides a treatment called “fat-derived stem cell therapy."

Jan 13 2019

The Verge – An autonomous food delivery robot from the startup service, Kiwi, burst into flames on a Berkeley, California walkway.

Jan 12 2019

The New York Times – The Department of Veterans Affairs is preparing to shift billions of dollars from government-run veterans’ hospitals to private health care providers, setting the stage for the biggest transformation of the veterans’ medical system in a generation.

 

Jan 11 2019

JD Supra – In a shift from its usual enforcement efforts, the Federal Energy Regulatory Commission (FERC) approved a settlement between its Office of Enforcement and Algonquin Gas Transmission, LLC for violating the terms of the FERC certificate for the Algonquin Incremental Market Project, which authorized Algonquin to expand its natural gas pipeline system in the northeast.

Jan 10 2019

MIT Technology Review – Since 2015, the US has adopted language in funding bills that prohibits the Food and Drug Administration from considering any application to create IVF children from embryos that have been genetically modified. But it has to be renewed every year.

Jan 10 2019

Drug Development Technology – The Wistar Institute, Penn Medicine and Inovio Pharmaceuticals have announced the receipt of FDA approval for commencement of a first-in-human clinical trial to probe the safety and tolerability of a new synthetic DNA-encoded monoclonal antibody (DMAb) therapy to prevent Zika virus infection.

Jan 10 2019

Stat – The drug industry’s foundering search for an Alzheimer’s cure is fueling a parallel quest by technology companies to help patients and family caregivers cope with the disease by using virtual reality software, robotics, and novel communication tools.

Jan 10 2019

MIT Technology Review – In 2018, several high-profile controversies involving AI served as a wake-up call for technologists, policymakers, and the public. The technology may have brought us welcome advances in many fields, but it can also fail catastrophically when built shoddily or applied carelessly.

Jan 10 2019

Regulatory Affairs Professionals Society – 2018 was a banner year for the Food and Drug Administration (FDA) in terms of an ever-increasing volume of announcements and official statements, but for FDA’s regulation of pharmaceutical companies’ promotional materials, the output was once again meager.

Jan 9 2019

The National Law Review – Even without urging from the White House Office of Science and Technology Policy, EPA, the FDA, and the U.S.

Jan 9 2019

Scientific American – Changes in brain cells’ DNA may be responsible—and if so, medicines already developed for other diseases might be used to treat it.